Servier
Servier Laboratories (French: Laboratoires Servier, often abbreviated to Servier) is an international pharmaceutical company governed by a non-profit foundation, with its headquarters in France (Suresnes).
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Asparlas | Calaspargase pegol | 2018-12-20 | ||
| Corlentor | Ivabradine | 2005-10-25 | 2026 | |
| Ivabradine anpharm | Ivabradine | 2015-09-08 | 2026 | |
| Lonsurf | Tipiracil, Trifluridine | 2016-04-25 | 2029-2037 | |
| Oncaspar | Pegaspargase | 1994-02-01 | ||
| Onivyde pegylated (previously onivyde) | Irinotecan trihydrate | 2016-10-14 | 2025-2036 | |
| Pixuvri | Pixantrone dimaleate | 2012-05-10 | ||
| Procoralan | Ivabradine | 2005-10-25 | 2026 | |
| Thymanax | Agomelatine | 2009-02-19 | ||
| Tibsovo | Ivosidenib | 2018-07-20 | 2030-2039 | |
| Valdoxan | Agomelatine | 2009-02-19 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use